LLY - Eli Lilly CFO Anat Ashkenazi to resign June, 05 2024 08:00 AM Eli Lilly and Company 2024-06-05 08:00:24 ET More on Eli Lilly Eli Lilly's Growth And Challenges: A Cautious Buy Eli Lilly: Addressing Supply Challenges Should Accelerate Growth Eli Lilly wins favorable terms for obesity drug use in U.K. Eli Lilly sees improving availability of GLP-1 drugs Mounjaro and Zepbound For further details see: Eli Lilly CFO Anat Ashkenazi to resign